Professor Yury Gogotsi from Drexel University, USA, has won the 2017 Energy Storage Materials Award, which is awarded by the journal Energy Storage Materials. The Award will be presented to Professor Gogotsi at the ICEnSM 2017 (2017 International Conference on Energy Storage Materials), which will be held in Shenzhen, China, on Nov. 18-21, 2017.
The award, which is sponsored by Elsevier, gives special recognition to a person who has accomplished outstanding achievements in energy storage materials and devices.
Professor Yury Gogotsi is recognized as one of the leaders in materials for electrochemical capacitors. His seminal work on carbon nanomaterials helped to better understand the mechanisms of capacitive energy storage. He introduced new materials to the field, such as carbon onions, and invented new technologies, such as electrochemical flow capacitors. Professor Gogotsi's recent work has concentrated on development of a new family of two-dimensional transition metal carbides and nitrides (MXenes), which he and his colleagues at Drexel University discovered in 2011. He is the author of over 500 of refereed journal papers and co-inventor of more than 60 inventions with patents issued or filed. He has an H-index of 92/109 (Web of Science/Google Scholar) and was recognized as a Highly Cited Researcher by Thomson-Reuters/Clarivate Analytics in 2014-2017. Dr. Gogotsi is Charles T. and Ruth M. Bach Professor, Distinguished University Professor and Director of the A.J. Drexel Nanomaterials Institute at Drexel University. He is also a Distinguished Foreign Professor at Jilin University, China.
Professor Gogotsi has received numerous awards for his work, including the European Carbon Association Award, the S. Somiya Award from the International Union of Materials Research Societies, the Nano Energy award from Elsevier, the International Nanotechnology Prize (RUSNANOPrize), and R&D 100 Award from R&D Magazine (twice). He is also a Fellow of the American Association for Advancement of Science (AAAS), Materials Research Society, American Ceramic Society, the Electrochemical Society, Royal Society of Chemistry, NanoSMAT Society, as well as an Academician of the World Academy of Ceramics.
Source: https://www.journals.elsevier.com
MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 
CanbioSe Project Meeting and Project Workshop was held at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.
Dr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.
Director of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.
MX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.
CANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.
MRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 
Meeting during the MXene international conference held in Drexel University on Aug. 3, 2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.
Presenting our recent collaborative research paper on MXene use for PPT anticancer therapy, the biocompatibility of MXenes in vitro and in vivo studies: